Debt to Equity Ratio Chart

View Debt to Equity Ratio for BIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1996. Start Trial.
Date Value
June 30, 2026 0.191
March 31, 2026 0.2012
December 31, 2025 0.1859
September 30, 2025 0.2071
June 30, 2025 0.1973
March 31, 2025 0.205
December 31, 2024 0.2093
September 30, 2024 0.1854
June 30, 2024 0.2054
March 31, 2024 0.1546
December 31, 2023 0.1608
September 30, 2023 0.1671
June 30, 2023 0.1649
March 31, 2023 0.1426
December 31, 2022 0.1455
September 30, 2022 0.1644
June 30, 2022 0.1572
March 31, 2022 0.1389
December 31, 2021 0.0171
September 30, 2021 0.0154
June 30, 2021 0.0193
March 31, 2021 0.0218
December 31, 2020 0.024
September 30, 2020 0.0744
June 30, 2020 0.0894
Date Value
March 31, 2020 0.1049
December 31, 2019 0.1131
September 30, 2019 0.132
June 30, 2019 0.1226
March 31, 2019 0.1394
December 31, 2018 0.1093
September 30, 2018 0.0899
June 30, 2018 0.095
March 31, 2018 0.0969
December 31, 2017 0.1485
September 30, 2017 0.1527
June 30, 2017 0.1547
March 31, 2017 0.1606
December 31, 2016 0.168
September 30, 2016 0.1607
June 30, 2016 0.1661
March 31, 2016 0.1707
December 31, 2015 0.1743
September 30, 2015 0.1795
June 30, 2015 0.1849
March 31, 2015 0.1983
December 31, 2014 0.1995
September 30, 2014 0.2009
June 30, 2014 0.1944
March 31, 2014 0.1959

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 0.8077
Agilent Technologies, Inc. 0.4711
Danaher Corp. 0.5298
Illumina, Inc. 0.8904
Revvity, Inc. 0.4623